A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

NCT03877718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine
Pain
Nausea
Vomiting
Aura

Interventions

DRUG: Arm 1: CL-H1T
DRUG: Arm 2: CL-H1T
DRUG: Arm 3: Sumatriptan Succinate 100 mg capsule
DRUG: Arm 4: Promethazine HCl 18.75 mg
DRUG: Arm 5: Promethazine HCl 37.5 mg
OTHER: Placebo

Sponsor

Charleston Laboratories, Inc